We are live on
!
Find out more
AG
Artal Group Portfolio holdings
AUM
$931M
1-Year Est. Return
41.63%
This Fund
S&P 500
This Quarter
Est. Return
-4.94%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$3.07B
AUM Growth
-$107M
(-3.4%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
75.54%
Holding
110
New
22
Increased
17
Reduced
17
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOUS
Anywhere Real Estate
HOUS
|
+$9.05M |
| 2 |
Terex
TEX
|
+$8.34M |
| 3 |
United Airlines
UAL
|
+$8.05M |
| 4 |
Goldman Sachs
GS
|
+$6.44M |
| 5 |
MTOR
MERITOR, Inc.
MTOR
|
+$5.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$26M |
| 2 |
Apple
AAPL
|
+$23.2M |
| 3 |
MetLife
MET
|
+$18.3M |
| 4 |
ONIT
Onity Group
ONIT
|
+$17.6M |
| 5 |
ACOR
Acorda Therapeutics
ACOR
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.72% |
| 2 | Consumer Discretionary | 35.8% |
| 3 | Healthcare | 25.32% |
| 4 | Industrials | 0.67% |
| 5 | Financials | 0.63% |
Similar funds
BCM
ACM
SAM
NS
PA
ACM
CICI
CAM
Artal Group's Q3 2013 Portfolio in Review
As of Q3 2013, Artal Group held 110 positions worth $3.07B, down 3.4% from $3.18B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Artal Group withdrew a net $138M in Q3 2013, closing 30 positions and reducing 17 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $26M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Artal Group opened a new position in Anywhere Real Estate worth $8.6M.
- Artal Group's largest Q3 2013 buy was Anywhere Real Estate: 200,000 shares worth $8.6M.
- Artal Group added most to Ford in Q3 2013, an estimated $5.07M increase.
- Artal Group's biggest Q3 2013 reduction was Acorda Therapeutics, cutting an estimated $14.5M.
- Artal Group fully exited ONYX PHARMACEUTICALS INC in Q3 2013, selling an estimated $26M.
- Artal Group's ten largest holdings make up 76% of its $3.07B portfolio in Q3 2013.
- Artal Group opened 22 new positions and closed 30 in Q3 2013.
- Artal Group's portfolio value fell 3.4% quarter-over-quarter to $3.07B.
Based on Artal Group's 13F filing for Q3 2013, filed 14 Nov 2013.